SENS
Senseonics Holdings, Inc. NASDAQ Listed Dec 22, 2015$6.36
-5.64%
vs $6.74
Mkt Cap $265.4M
52w Low $5.00
20.4% of range
52w High $11.68
50d MA $6.45
200d MA $7.05
P/E (TTM)
-2.9x
EV/EBITDA
—
P/B
4.3x
Debt/Equity
0.7x
ROE
-113.2%
P/FCF
-4.4x
RSI (14)
41.80
ATR (14)
$0.47
Beta
1.05
50d MA
$6.45
200d MA
$7.05
Avg Volume
781.9K
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
20451 Seneca Meadows Parkway · Germantown, MD 20876-7005 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | AMC | -0.69 | -0.71 | -3.6% | 5.36 | +0.2% | -6.2% | +14.7% | -0.2% | -4.5% | +5.8% | — |
| Mar 2, 2026 | AMC | -0.43 | -0.46 | -7.0% | 8.33 | -8.2% | -18.0% | +0.6% | -11.1% | -2.5% | +5.9% | — |
| Nov 5, 2025 | AMC | -0.33 | -0.43 | -30.3% | 6.73 | +0.0% | -7.6% | -3.4% | +5.3% | +2.8% | +1.2% | — |
| Aug 6, 2025 | AMC | -0.40 | -0.40 | +0.0% | 9.73 | -5.4% | -4.8% | +7.0% | -5.9% | +1.5% | +1.8% | — |
| May 8, 2025 | AMC | -0.02 | -0.02 | +0.0% | 14.74 | -5.0% | -15.2% | -4.0% | -0.8% | -2.7% | -5.1% | — |
| Mar 3, 2025 | AMC | -0.03 | -0.02 | +33.3% | 17.40 | -19.7% | -19.3% | -1.3% | -11.4% | +5.3% | -9.7% | — |
| Nov 7, 2024 | AMC | -0.03 | -0.04 | -17.6% | 7.05 | -2.4% | -12.5% | +4.9% | -2.6% | -5.1% | -5.2% | — |
| Aug 8, 2024 | AMC | -0.03 | -0.03 | -2.4% | 8.10 | -3.7% | -6.8% | +2.0% | +2.3% | +0.5% | +4.0% | — |
| May 13, 2024 | AMC | -0.03 | -0.03 | +0.0% | 8.88 | +1.4% | +10.4% | +1.1% | -0.8% | -1.3% | -3.3% | — |
| Feb 29, 2024 | AMC | -0.02 | -0.03 | -29.3% | 14.04 | -12.4% | -10.5% | -8.4% | -1.1% | -2.4% | +6.4% | — |
| Nov 9, 2023 | AMC | -0.04 | -0.04 | -14.3% | 10.26 | +3.3% | +1.9% | +6.1% | +4.2% | +4.7% | -1.4% | — |
| Aug 10, 2023 | AMC | -0.04 | -0.04 | -3.4% | 14.75 | -5.1% | -8.5% | -9.6% | -6.6% | -7.0% | -2.5% | — |
| May 9, 2023 | AMC | -0.03 | -0.03 | -20.0% | 12.94 | -1.5% | +24.0% | -1.5% | -4.3% | -2.6% | -3.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 6 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.73 | $6.73 | +0.0% | -7.6% | -3.4% | +5.3% | +2.8% | +1.2% |
| Nov 5 | Barclays | Maintains | Overweight → Overweight | — | $6.69 | $6.56 | -1.9% | +0.6% | -7.6% | -3.4% | +5.3% | +2.8% |
| Nov 5 | TD Cowen | Maintains | Buy → Buy | — | $6.69 | $6.56 | -1.9% | +0.6% | -7.6% | -3.4% | +5.3% | +2.8% |
| Jul 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $9.79 | $9.82 | +0.3% | +1.1% | -0.4% | +1.4% | -0.6% | -0.8% |
| Mar 5 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $14.04 | $13.90 | -1.0% | -1.3% | -11.4% | +5.3% | -9.7% | +2.8% |
| Nov 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.67 | $5.76 | +1.6% | -0.2% | +6.7% | +5.1% | +0.0% | +1.6% |
| Aug 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $7.88 | $7.88 | +0.0% | +0.5% | +4.0% | +0.2% | -1.0% | -2.7% |
| Mar 11 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $12.50 | $12.41 | -0.7% | -2.8% | +0.8% | -7.8% | -1.0% | +3.7% |
| Nov 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $11.10 | $11.10 | +0.0% | +4.2% | +4.7% | -1.4% | -1.5% | +0.2% |
| Aug 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $12.20 | $12.20 | +0.0% | -6.6% | -7.0% | -2.5% | +2.6% | -0.7% |
| May 11 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.04 | $16.40 | +2.2% | -1.5% | -4.3% | -2.6% | -3.5% | +7.1% |
| Jul 25 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $25.80 | $25.20 | -2.3% | -2.3% | -6.3% | +7.6% | +4.7% | -3.0% |
| Aug 19 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $62.40 | $64.80 | +3.8% | +1.6% | +9.8% | +4.0% | +1.1% | +1.6% |
| Apr 1 | SVB Leerink | Downgrade | Outperform → Market Perform | — | $52.80 | $54.20 | +2.7% | -2.3% | -1.2% | +2.0% | -2.3% | +2.8% |
| Mar 5 | Raymond James | Downgrade | Market Perform → Underperform | — | $53.80 | $51.40 | -4.5% | -7.8% | +1.6% | +15.1% | +5.9% | +8.1% |
| Mar 5 | SVB Leerink | Maintains | Outperform → Outperform | — | $53.80 | $51.40 | -4.5% | -7.8% | +1.6% | +15.1% | +5.9% | +8.1% |
| Jan 21 | BTIG | Downgrade | Buy → Neutral | — | $53.40 | $49.80 | -6.7% | -9.4% | -4.5% | +27.7% | -3.7% | -11.6% |
| Jan 20 | Craig-Hallum | Downgrade | Hold → Sell | — | $57.00 | $66.60 | +16.8% | -6.3% | -9.4% | -4.5% | +27.7% | -3.7% |
| Aug 11 | Craig-Hallum | Upgrade | Sell → Hold | — | $10.17 | $11.25 | +10.6% | +4.6% | -2.3% | +2.0% | -2.9% | +1.6% |
| Aug 11 | BTIG | Upgrade | Neutral → Buy | — | $10.17 | $11.25 | +10.6% | +4.6% | -2.3% | +2.0% | -2.9% | +1.6% |
| Jun 10 | SVB Leerink | Maintains | Outperform → Outperform | — | $10.36 | $8.80 | -15.1% | -12.4% | -11.3% | +1.9% | -2.4% | +0.0% |
| Jun 10 | Stifel | Maintains | Buy → Buy | — | $10.36 | $8.80 | -15.1% | -12.4% | -11.3% | +1.9% | -2.4% | +0.0% |
| May 21 | UBS | Maintains | Sell → Sell | — | $9.50 | $9.50 | +0.0% | -2.8% | +0.7% | +2.7% | +5.2% | -4.4% |
| Mar 13 | Canaccord Genuity | Maintains | Hold → Hold | — | $18.14 | $16.00 | -11.8% | -6.0% | -16.8% | +8.2% | -19.3% | +3.4% |
| Nov 13 | UBS | Maintains | Sell → Sell | — | $20.40 | $17.60 | -13.7% | -14.7% | +0.0% | -0.6% | -0.6% | -1.3% |
| Nov 13 | Canaccord Genuity | Downgrade | Buy → Hold | — | $20.40 | $17.60 | -13.7% | -14.7% | +0.0% | -0.6% | -0.6% | -1.3% |
| Oct 23 | Stifel | Maintains | Buy → Buy | — | $18.94 | $20.80 | +9.8% | +6.7% | +1.0% | +9.8% | +0.9% | -0.9% |
| Jul 5 | Raymond James | Downgrade | Outperform → Market Perform | — | $37.80 | $37.20 | -1.6% | -3.2% | -4.9% | -1.7% | +5.3% | -3.9% |
| Jan 29 | Piper Sandler | Maintains | Neutral → Neutral | — | $51.00 | $50.80 | -0.4% | -3.5% | -0.8% | +2.9% | -4.0% | -2.1% |
| Nov 28 | UBS | Maintains | Sell → Sell | — | $68.00 | $65.00 | -4.4% | -5.0% | +4.3% | +0.9% | -2.9% | -8.8% |
| Aug 24 | Dougherty | Maintains | Buy → Buy | — | $68.80 | $71.80 | +4.4% | -1.2% | +5.3% | +1.7% | +5.8% | +0.8% |
| Jun 22 | Raymond James | Maintains | Outperform → Outperform | — | $99.60 | $103.80 | +4.2% | -1.4% | -5.1% | -7.5% | -1.9% | -0.5% |
| Apr 4 | Guggenheim | Maintains | Buy → Buy | — | $61.00 | $61.80 | +1.3% | +7.9% | +7.0% | +5.7% | +1.3% | -0.8% |
| Sep 27 | B. Riley FBR | Maintains | Buy → Buy | — | $78.40 | $79.20 | +1.0% | +1.0% | -4.3% | +2.6% | +0.3% | -2.3% |
| Apr 12 | Leerink Swann | Maintains | Outperform → Outperform | — | $59.40 | $61.60 | +3.7% | +0.0% | +10.8% | +1.2% | +1.2% | -3.0% |
| Apr 12 | Raymond James | Maintains | Outperform → Outperform | — | $59.40 | $61.60 | +3.7% | +0.0% | +10.8% | +1.2% | +1.2% | -3.0% |
| Apr 12 | BTIG Research | Maintains | Buy → Buy | — | $59.40 | $61.60 | +3.7% | +0.0% | +10.8% | +1.2% | +1.2% | -3.0% |
| Apr 12 | Canaccord Genuity | Maintains | Buy → Buy | — | $59.40 | $61.60 | +3.7% | +0.0% | +10.8% | +1.2% | +1.2% | -3.0% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 12, 2026 | ROEDER DOUGLAS A | — | Buy | 22,686 | $5.56 | $126K | 144,635 | +5.82% | +3.07% |
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
SENS entered into local purchase agreements that could expand distribution channels or secure supply chains, potentially improving operational efficiency and supporting revenue growth in key markets.
Mar 12
8-K
Senseonics Holdings, Inc. -- 8-K Filing
I cannot provide a meaningful analysis of this filing because the summary provided contains only signature blocks and formatting information without substantive disclosure of the actual business event or transaction details.
Mar 2
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 1,617,197 | $11M | New | Mar 2026 |
| 2 | Millennium Management | 560,371 | $4M | Added | Mar 2026 |
| 3 | Marshall Wace, Llp | 464,375 | $3M | Added | Mar 2026 |
| 4 | Ubs Group Ag | 448,229 | $3M | Added | Mar 2026 |
| 5 | Susquehanna International Group, Llp | 230,538 | $2M | Added | Mar 2026 |
| 6 | Hood River Capital Management Llc | 186,426 | $1M | Reduced | Mar 2026 |
| 7 | Morgan Stanley | 128,782 | $711K | New | Dec 2025 |
| 8 | Jane Street Group, Llc | 123,479 | $682K | New | Dec 2025 |
| 9 | Northern Trust Corp | 82,277 | $548K | — | Mar 2026 |
| 10 | Citadel Advisors Llc | 77,162 | $514K | New | Mar 2026 |
| 11 | Bank Of America Corp /de/ | 56,964 | $379K | New | Mar 2026 |
| 12 | Sei Investments Co | 49,592 | $330K | Reduced | Mar 2026 |
| 13 | Tocqueville Asset Management L.p. | 33,500 | $223K | New | Mar 2026 |
| 14 | Pathstone Holdings, Llc | 25,000 | $166K | — | Mar 2026 |
| 15 | Centiva Capital, Lp | 24,662 | $164K | New | Mar 2026 |
| 16 | Symmetry Partners, Llc | 23,385 | $129K | New | Dec 2025 |
| 17 | Catalyst Funds Management Pty Ltd | 15,300 | $102K | New | Mar 2026 |
| 18 | Fmr Llc | 14,736 | $98K | Added | Mar 2026 |
| 19 | Captrust Financial Advisors | 13,975 | $93K | — | Mar 2026 |
| 20 | Hudson Bay Capital Management Lp | 15,450 | $85K | New | Dec 2025 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$265.4M
Enterprise Value
$206.9M
P/E (TTM)
-2.94x
Forward P/E
—
PEG Ratio
0.10x
P/B
4.35x
P/S
6.52x
P/FCF
-4.41x
EV/EBITDA
—
Shares Out
41.7M
Financials (TTM)
Revenue
$40.7M
Net Income
-$87.2M
EBITDA
-$80.8M
Free Cash Flow
-$60.2M
Op Cash Flow
-$59.1M
EPS Basic
$-1.66
EPS Diluted
$-2.16
EPS Forward
$-2.86
Gross Margin
52.1%
Op Margin
-213.0%
Net Margin
-214.2%
Balance Sheet
Total Assets
$126.3M
Total Liab.
$65.2M
Total Equity
$61.0M
Cash
$94.0M
LT Debt
$35.6M
Book Value/Sh
$1.46
Debt/Equity
0.68x
Current Ratio
4.83
Quick Ratio
4.55
Returns & Growth
ROE
-113.2%
ROA
-54.7%
ROIC
-66.7%
Rev Growth YoY
+56.9%
EPS Growth YoY
+33.6%
Price Returns
2W
+16.7%
1M
+2.7%
3M
-17.9%
6M
+9.9%
12M
-35.1%
Technicals
52W High
$11.68
52W Low
$5.00
50d MA
$6.45
200d MA
$7.05
RSI (14)
41.80
ATR (14)
$0.47
Beta
1.05
Avg Volume
782K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$9.00
High
$9.00
Low
$9.00
Median
$9.00
Data updated apr 27, 2026 12:44am
· Source: financialmodelingprep.com